Blog

Pacific Neuroscience Institute® experts discuss the signs and symptoms of anxiety. Discover the latest treatment and innovations at PNI's Pacific Treatment & Research In Psychedelics (TRIP) program.

Vikki was walking her dog and listening to NPR in Santa Monica one day, when she heard an advertisement for an unusual medical trial. Pacific Neuroscience Institute was studying whether psilocybin, the active compound in magic mushrooms, could help alcoholics kick their habit.

Cancer patients may find relief from mental anguish with ketamine-assisted therapy available at Saint John’s Health Center and Pacific Neuroscience Institute ® (PNI).

After years of unsuccessful therapy, Vikki transformed her life for the better with psychedelic-assisted therapy at PNI's Pacific Treatment & Research In Psychedelics (TRIP). Learn more about her journey toward healing.

Psilocybin and many other psychedelics are broadly prohibited under federal law. But US researchers at the PNI's Pacific Treatment & Research In Psychedelics (TRIP) program have been legally scrutinizing their use in a score of clinical trials.

At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.

After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).

Ketamine therapy is a treatment approach that uses low doses of ketamine, a dissociative anesthetic medication, to manage various mental health conditions, such as treatment-resistant depression, anxiety disorders, and post-traumatic stress disorder (PTSD). Ketamine is approved for use at high doses as an anesthetic in...

Pacific Neuroscience Institute teams in Neurology and Neurosurgery contribute to High Performing Hospitals in US News & World Report rankings.

This year, six of Pacific Neuroscience Institute’s physicians were included in Los Angeles Magazine’s April 2022 roster of “L.A.’s Top Doctors.”